Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats

被引:7
|
作者
Ikehara, O
Nishimura, H
Naito, T
Higuchi, C
Sanaka, T
机构
[1] Shimizu Pharmaceut Co Ltd, CAPD Div, Dept Res & Dev, Shizuoka, Japan
[2] Tokyo Womens Med Univ, Daini Hosp Med Ctr, Dept Nephrol & Blood Purificat, Tokyo, Japan
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2005年 / 100卷 / 01期
关键词
biocompatibility of PD treatment; glucose degradation products; imprint; peritoneal dialysis solution; peritoneal membrane; pH;
D O I
10.1159/000084110
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In vitro studies have shown that pH and glucose degradation products (GDPs) in the dialysate are determinant factors for the biocompatibility of peritoneal dialysis (PD) treatment. The present study was thus designed to evaluate whether a newly developed PD solution, which features neutral pH levels and a low GDP concentration, influences tissue damage of the peritoneal membrane in an in vivo setting, and which factor is more critical to the histological changes. Methods: Rats were injected 3 times per day during 1 or 4 weeks with 10 ml of various PD fluids ( group G, acidic pH, high GDPs; group S, neutral pH, low GDPs; or group A, acidic pH, low GDPs). When the experimental period was over, the mesothelial cell monolayers of the animals were taken and studied with population analysis, and peritoneal membranes were obtained from the abdominal wall for immunohistochemical examination with proliferating cell nuclear antigen ( PCNA) and for measurement of thickness of the peritoneal specimens. Results: The density of the mesothelial cell monolayer and the number of fibroblast-like cells in group S were significantly less than in group G at 1 and 4 weeks' injection. PCNA-positive nuclei in group S were significantly less than in group G for only the 1-week injection set ( group G, 2.03 +/- 0.95; group S, 0.85 +/- 1.18 nuclei/ 1 x 10(4) mu m(2)). At 4 weeks, the peritoneal thickness of group S (6.32 +/- 0.53 mu m) was significantly less than that of group G (7.94 +/- 0.77 mu m), There was no significant difference between groups S and A throughout the whole study period except for the result of the number of fibroblast-like cells. Conclusion: These results indicate that a PD solution with a neutral pH and low GDPs proved more biocompatible with the peritoneal membrane than a solution with an acidic pH and high GDPs. Furthermore, the level of the GDPs has more impact on tissue damage of the peritoneal membrane than the pH in the short term. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:E30 / E39
页数:10
相关论文
共 50 条
  • [1] The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients
    Cho, Yeoungjee
    Johnson, David W.
    Badve, Sunil V.
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    Wiggins, Kathryn J.
    KIDNEY INTERNATIONAL, 2013, 84 (05) : 969 - 979
  • [2] EFFECT OF GLUCOSE DEGRADATION PRODUCTS ON PERITONEAL FUNCTION IN RATS ON CHRONIC PERITONEAL DIALYSIS
    Kuzlan-Pawlaczyk, Malgorzata
    Pawlaczyk, Krzysztof
    Polubinska, Alicja
    Wisniewska-Elnur, Justyna
    Gorska, Kinga
    Wu, George
    Paul, Tam
    Carlsson, Ola
    Wieslander, Anders
    Czekalski, Stanislaw
    Breborowicz, Andrzej
    NEPHROLOGY, 2005, 10 : A66 - A67
  • [3] Prolonged preservation of rat peritoneal mesothelial cells (RPMC) and rat peritoneal fibroblasts (RPFB) with neutral pH peritoneal dialysis solution depleted of glucose degradation products (GDPs)
    Horiuchi T.
    Inoue T.
    Nagasawa K.
    Clinical and Experimental Nephrology, 2001, 5 (4) : 257 - 264
  • [4] Effects of incremental peritoneal dialysis with low glucose-degradation product neutral pH solution on clinical outcomes
    Yeter, Hasan Haci
    Altunok, Murat
    Cankaya, Erdem
    Yildirim, Saliha
    Akturk, Serkan
    Bakirdogen, Serkan
    Akoglu, Hadim
    Bulut, Mesudiye
    Sahutoglu, Tuncay
    Erdut, Arda
    Ozkahya, Mehmet
    Koc, Yener
    Tunca, Onur
    Kara, Ekrem
    Erek, Muge
    Polat, Mehmet
    Akagun, Tulin
    Guz, Galip
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (09) : 3123 - 3132
  • [5] Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis
    Schaefer, Betti
    Bartosova, Maria
    Macher-Goeppinger, Stephan
    Sallay, Peter
    Voros, Peter
    Ranchin, Bruno
    Vondrak, Karel
    Ariceta, Gema
    Zaloszyc, Ariane
    Bayazit, Aysun K.
    Querfeld, Uwe
    Cerkauskiene, Rimante
    Testa, Sara
    Taylan, Christina
    VandeWalle, Johan
    Yap, YokChin
    Krmar, Rafael T.
    Buescher, Rainer
    Muhlig, Anne K.
    Drozdz, Dorota
    Caliskan, Salim
    Lasitschka, Felix
    Fathallah-Shaykh, Sahar
    Verrina, Enrico
    Klaus, Gunter
    Arbeiter, Klaus
    Bhayadia, Raj
    Melk, Anette
    Romero, Philipp
    Warady, Bradley A.
    Schaefer, Franz
    Ujszaszi, Akos
    Schmitt, Claus Peter
    KIDNEY INTERNATIONAL, 2018, 94 (02) : 419 - 429
  • [6] NEUTRAL SOLUTION LOW IN GLUCOSE DEGRADATION PRODUCTS IS ASSOCIATED WITH LESS PERITONEAL FIBROSIS AND VASCULAR SCLEROSIS IN PATIENTS RECEIVING PERITONEAL DIALYSIS
    Kawanishi, Kunio
    Honda, Kazuho
    Tsukada, Misao
    Oda, Hideaki
    Nitta, Kosaku
    PERITONEAL DIALYSIS INTERNATIONAL, 2013, 33 (03): : 242 - 251
  • [7] Neutral pH peritoneal dialysis solution improve peritoneal function.
    Nishina, M
    Tanabe, R
    Endoh, H
    Endoh, M
    Sakai, H
    Hirahara, L
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 482A - 482A
  • [8] Systemic and Local Impact of Glucose and Glucose Degradation Products in Peritoneal Dialysis Solution
    Kim, Yong-Lim
    Cho, Jang-Hee
    Choi, Ji-Young
    Kim, Chan-Duck
    Park, Sun-Hee
    JOURNAL OF RENAL NUTRITION, 2013, 23 (03) : 218 - 222
  • [9] The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial
    Johnson, David W.
    Brown, Fiona G.
    Clarke, Margaret
    Boudville, Neil
    Elias, Tony J.
    Foo, Marjorie W. Y.
    Jones, Bernard
    Kulkarni, Hemant
    Langham, Robyn
    Ranganathan, Dwarakanathan
    Schollum, John
    Suranyi, Michael G.
    Tan, Seng H.
    Voss, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (12) : 4445 - 4453
  • [10] Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products
    Mortier, S
    De Vriese, AS
    Van de Voorde, J
    Schaub, TP
    Passlick-Deetjen, J
    Lameire, NH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 480 - 489